These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7972316)

  • 1. Polymeric ocular drug delivery system for controlled release of norfloxacin. Part 2: In vivo characterization.
    Mukharya A; Jain SK; Dixit VK
    Pharmazie; 1994 Sep; 49(9):694-5. PubMed ID: 7972316
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymeric ocular drug delivery system for controlled release of norfloxacin. Part 1: In vitro characterization.
    Mukharya A; Jain SK; Dixit VK
    Pharmazie; 1994 Aug; 49(8):618-9. PubMed ID: 7938155
    [No Abstract]   [Full Text] [Related]  

  • 3. Functionalized chitosan/NIPAM (HEMA) hybrid polymer networks as inserts for ocular drug delivery: synthesis, in vitro assessment, and in vivo evaluation.
    Verestiuc L; Nastasescu O; Barbu E; Sarvaiya I; Green KL; Tsibouklis J
    J Biomed Mater Res A; 2006 Jun; 77(4):726-35. PubMed ID: 16555266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin exhibits negligible serum concentrations after repeated conjunctival instillation in children.
    Drago F; La Manna C; Marino V; Marino A; Emmi I; Reibaldi A
    Br J Clin Pharmacol; 1998 Sep; 46(3):272-4. PubMed ID: 9764971
    [No Abstract]   [Full Text] [Related]  

  • 7. Norfloxacin-loaded chitosan sponges as wound dressing material.
    Denkbaş EB; Oztürk E; Ozdemir N; Keçeci K; Agalar C
    J Biomater Appl; 2004 Apr; 18(4):291-303. PubMed ID: 15070516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioerodible polymers for ocular drug delivery.
    Deshpande AA; Heller J; Gurny R
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine.
    Lin HR; Sung KC; Vong WJ
    Biomacromolecules; 2004; 5(6):2358-65. PubMed ID: 15530052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
    Vandamme TF; Brobeck L
    J Control Release; 2005 Jan; 102(1):23-38. PubMed ID: 15653131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.
    Griset AP; Walpole J; Liu R; Gaffey A; Colson YL; Grinstaff MW
    J Am Chem Soc; 2009 Feb; 131(7):2469-71. PubMed ID: 19182897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stimuli-sensitive hydrogels and polymers. An effective tool in ocular therapeutic].
    Alvarez Lorenzo C; Concheiro Nine A
    Arch Soc Esp Oftalmol; 2002 Jan; 77(1):3-4. PubMed ID: 11813112
    [No Abstract]   [Full Text] [Related]  

  • 16. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
    Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P
    Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
    Attar M; Shen J; Ling KH; Tang-Liu D
    Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of mucoadhesive polymers in ocular drug delivery.
    Ludwig A
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1595-639. PubMed ID: 16198021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposits of topical norfloxacin in the treatment of bacterial keratitis.
    Castillo A; Benitez del Castillo JM; Toledano N; Diaz-Valle D; Sayagues O; Garcia-Sanchez J
    Cornea; 1997 Jul; 16(4):420-3. PubMed ID: 9220239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucoadhesive polymeric platforms for controlled drug delivery.
    Andrews GP; Laverty TP; Jones DS
    Eur J Pharm Biopharm; 2009 Mar; 71(3):505-18. PubMed ID: 18984051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.